151 related articles for article (PubMed ID: 37794797)
1. Tucidinostat restores CCR4 expression in adult T-cell leukemia/lymphoma.
Kawata T; Shimizu T; Shindo T; Fujiwara K; Morimoto S; Watanabe M
Haematologica; 2024 Mar; 109(3):1007-1009. PubMed ID: 37794797
[No Abstract] [Full Text] [Related]
2. Molecular analysis of loss of CCR4 expression during mogamulizumab monotherapy in an adult T cell leukemia/lymphoma patient.
Taguchi M; Imaizumi Y; Sasaki D; Higuchi T; Tsuruda K; Hasegawa H; Taguchi J; Sawayama Y; Imanishi D; Hata T; Yanagihara K; Yoshie O; Miyazaki Y
Ann Hematol; 2015 Apr; 94(4):693-5. PubMed ID: 25338968
[No Abstract] [Full Text] [Related]
3. CCR4 mutations associated with superior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatment.
Sakamoto Y; Ishida T; Masaki A; Murase T; Yonekura K; Tashiro Y; Tokunaga M; Utsunomiya A; Ito A; Kusumoto S; Iida S; Ueda R; Inagaki H
Blood; 2018 Aug; 132(7):758-761. PubMed ID: 29930010
[No Abstract] [Full Text] [Related]
4. Immunohistochemistry for CCR4 C-terminus predicts CCR4 mutations and mogamulizumab efficacy in adult T-cell leukemia/lymphoma.
Fujii K; Sakamoto Y; Masaki A; Murase T; Tashiro Y; Yonekura K; Utsunomiya A; Ito A; Kusumoto S; Iida S; Ueda R; Ishida T; Inagaki H
J Pathol Clin Res; 2021 Jan; 7(1):52-60. PubMed ID: 33022137
[TBL] [Abstract][Full Text] [Related]
5. CCR4 is rarely expressed in CCR4-mutated T/NK-cell lymphomas other than adult T-cell leukemia/lymphoma.
Sakamoto Y; Fujii K; Murase S; Nakano S; Masaki A; Murase T; Kusumoto S; Iida S; Utsunomiya A; Ueda R; Ishida T; Inagaki H
Int J Hematol; 2019 Oct; 110(4):389-392. PubMed ID: 31468320
[TBL] [Abstract][Full Text] [Related]
6. CCR4 drives ATLL jail break.
Shannon KM
J Exp Med; 2014 Dec; 211(13):2485. PubMed ID: 25512583
[No Abstract] [Full Text] [Related]
7. CCR4 frameshift mutation identifies a distinct group of adult T cell leukaemia/lymphoma with poor prognosis.
Yoshida N; Miyoshi H; Kato T; Sakata-Yanagimoto M; Niino D; Taniguchi H; Moriuchi Y; Miyahara M; Kurita D; Sasaki Y; Shimono J; Kawamoto K; Utsunomiya A; Imaizumi Y; Seto M; Ohshima K
J Pathol; 2016 Apr; 238(5):621-6. PubMed ID: 26847489
[TBL] [Abstract][Full Text] [Related]
8. cDNA-Based Mutation Screening Using a Combination of High-Resolution Melting Curve and Fragment Analysis Facilitates Efficient CCR4 Mutation Analysis in Adult T-Cell Leukemia/Lymphoma.
Mizuta S; Yamane N; Mononobe S; Komai T; Koba Y; Kawata T; Ukyo N; Tamekane A; Watanabe M
Am J Clin Pathol; 2020 Jul; 154(2):236-241. PubMed ID: 32367127
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitors downregulate CCR4 expression and decrease mogamulizumab efficacy in CCR4-positive mature T-cell lymphomas.
Kitadate A; Ikeda S; Abe F; Takahashi N; Shimizu N; Matsue K; Tagawa H
Haematologica; 2018 Jan; 103(1):126-135. PubMed ID: 29025909
[TBL] [Abstract][Full Text] [Related]
10. Gain-of-function CCR4 mutations in adult T cell leukemia/lymphoma.
Nakagawa M; Schmitz R; Xiao W; Goldman CK; Xu W; Yang Y; Yu X; Waldmann TA; Staudt LM
J Exp Med; 2014 Dec; 211(13):2497-505. PubMed ID: 25488980
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of Fra-2 promotes CCR4 expression and cell proliferation in adult T-cell leukemia.
Nakayama T; Hieshima K; Arao T; Jin Z; Nagakubo D; Shirakawa AK; Yamada Y; Fujii M; Oiso N; Kawada A; Nishio K; Yoshie O
Oncogene; 2008 May; 27(23):3221-32. PubMed ID: 18071306
[TBL] [Abstract][Full Text] [Related]
12. Dosing of a phase I study of KW-0761, an anti-CCR4 antibody, for adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma.
Suzuki R
J Clin Oncol; 2010 Aug; 28(23):e404-5; author reply e406. PubMed ID: 20566994
[No Abstract] [Full Text] [Related]
13. Loss of CCR4 antigen expression after mogamulizumab therapy in a case of adult T-cell leukaemia-lymphoma.
Ohno N; Kobayashi S; Ishigaki T; Yuji K; Kobayashi M; Sato K; Watanabe N; Tojo A; Uchimaru K
Br J Haematol; 2013 Dec; 163(5):683-5. PubMed ID: 23998261
[No Abstract] [Full Text] [Related]
14. Oral histone deacetylase inhibitor tucidinostat (HBI-8000) in patients with relapsed or refractory adult T-cell leukemia/lymphoma: Phase IIb results.
Utsunomiya A; Izutsu K; Jo T; Yoshida S; Tsukasaki K; Ando K; Choi I; Imaizumi Y; Kato K; Kurosawa M; Kusumoto S; Miyagi T; Ohtsuka E; Sasaki O; Shibayama H; Shimoda K; Takamatsu Y; Takano K; Yonekura K; Makita S; Taguchi J; Gillings M; Onogi H; Tobinai K
Cancer Sci; 2022 Aug; 113(8):2778-2787. PubMed ID: 35579212
[TBL] [Abstract][Full Text] [Related]
15. Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma.
Yamamoto K; Utsunomiya A; Tobinai K; Tsukasaki K; Uike N; Uozumi K; Yamaguchi K; Yamada Y; Hanada S; Tamura K; Nakamura S; Inagaki H; Ohshima K; Kiyoi H; Ishida T; Matsushima K; Akinaga S; Ogura M; Tomonaga M; Ueda R
J Clin Oncol; 2010 Mar; 28(9):1591-8. PubMed ID: 20177026
[TBL] [Abstract][Full Text] [Related]
16. Diffuse panbronchiolitis after humanized anti-CCR4 monoclonal antibody therapy for relapsed adult T-cell leukemia/lymphoma.
Kato K; Miyamoto T; Numata A; Nakaike T; Oka H; Yurino A; Kuriyama T; Mori Y; Yamasaki S; Muta T; Takenaka K; Iwasaki H; Teshima T; Akashi K
Int J Hematol; 2013 Mar; 97(3):430-2. PubMed ID: 23397210
[TBL] [Abstract][Full Text] [Related]
17. Furin-dependent CCL17-fused recombinant toxin controls HTLV-1 infection by targeting and eliminating infected CCR4-expressing cells in vitro and in vivo.
Hiyoshi M; Okuma K; Tateyama S; Takizawa K; Saito M; Kuramitsu M; Araki K; Morishita K; Okada S; Yamamoto N; Biragyn A; Yamaguchi K; Hamaguchi I
Retrovirology; 2015 Aug; 12():73. PubMed ID: 26289727
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of TP53 mutations in adult T-cell leukemia/lymphoma.
Sakamoto Y; Ishida T; Masaki A; Murase T; Takeshita M; Muto R; Iwasaki H; Ito A; Kusumoto S; Nakano N; Tokunaga M; Yonekura K; Tashiro Y; Iida S; Utsunomiya A; Ueda R; Inagaki H
Br J Haematol; 2021 Nov; 195(4):571-584. PubMed ID: 34405395
[TBL] [Abstract][Full Text] [Related]
19. Development of a novel Indium-111 radiolabeled mogamulizumab targeting CCR4 for imaging adult T-cell leukemia/lymphoma in vivo.
Shimizu Y; Koyasu S; Suzukida M; Izumi K; Kidera E; Shindo T; Saga T; Ono M; Takaori-Kondo A; Nakamoto Y
Ann Nucl Med; 2022 Mar; 36(3):319-326. PubMed ID: 35034259
[TBL] [Abstract][Full Text] [Related]
20. [Successful treatment with tucidinostat in a patient with relapsed adult T-cell leukemia/lymphoma following allogeneic hematopoietic stem cell transplantation].
Moriki A; Ito S; Horikita F; Tsutsumi Y
Rinsho Ketsueki; 2024; 65(1):18-23. PubMed ID: 38311384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
